Organizational success is tied to how effectively leaders and institutions integrate mental health into everyday operations, ...
In 2025, both new and returning member cohort contribution profit performed in line with expectations. Returning member contribution profit remained strong at $200 PMPM year-over-year. New member ...
Q4 2025 Management View CEO Andrew Toy stated the company achieved "full year adjusted EBITDA profitability, delivered a well-controlled medical cost trend and reestablished market-leading membership ...
For Bob Riney, president and CEO of Detroit-based Henry Ford Health, the high cost of healthcare is not a pricing problem — it reflects deeper structural flaws in the current financing system. “I ...
DAVOS, SWITZERLAND, January 23, 2026 / EINPresswire.com / — Gravie, one of the nation’s fastest growing health benefits innovators, will take the global stage next month as CEO Steve Wolin joins other ...
Q4 2025 earnings call recap: 2026 guidance, cost trends, contract exits, membership outlook, and breakeven EBITDA path—read now.
As ACA subsidies expire, U.S. families face soaring premiums, financial strain, and economic ripple effects, highlighting the ...
Thousands of portable power banks are being recalled across Canada. Federal safety officials have identified a fire risk with ...
Nigeria’s health care financing conversation has long been dominated by shortages: chronic underfunding, negligible insurance ...
Edmonton Journal on MSN
Alberta's dual-practice model could improve treatment capacity if done right: report
Alberta’s legislation allowing physicians to practice in both public and private care settings has drawn mixed reviews, but a ...
Research-driven insights reveal how wearables and wellness incentives could transform the U.S. health insurance ...
Drug pricing 2026 forces are reshaping pharmacy economics through Medicare negotiations, FTC actions, and federal pricing models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results